• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VPS35 和 retromer 功能障碍与帕金森病。

VPS35 and retromer dysfunction in Parkinson's disease.

机构信息

Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA.

出版信息

Philos Trans R Soc Lond B Biol Sci. 2024 Apr 8;379(1899):20220384. doi: 10.1098/rstb.2022.0384. Epub 2024 Feb 19.

DOI:10.1098/rstb.2022.0384
PMID:38368930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10874700/
Abstract

The () gene encodes a core component of the retromer complex essential for the endosomal sorting and recycling of transmembrane cargo. Endo-lysosomal pathway deficits are suggested to play a role in the pathogenesis of neurodegenerative diseases, including Parkinson's disease (PD). Mutations in cause a late-onset, autosomal dominant form of PD, with a single missense mutation (D620N) shown to segregate with disease in PD families. Understanding how the PD-linked D620N mutation causes retromer dysfunction will provide valuable insight into the pathophysiology of PD and may advance the identification of therapeutics. D620N VPS35 can induce LRRK2 hyperactivation and impair endosomal recruitment of the WASH complex but is also linked to mitochondrial and autophagy-lysosomal pathway dysfunction and altered neurotransmitter receptor transport. The clinical similarities between -linked PD and sporadic PD suggest that defects observed in cellular and animal models with the mutation may provide valuable insights into sporadic disease. In this review, we highlight the current knowledge surrounding VPS35 and its role in retromer dysfunction in PD. We provide a critical discussion of the mechanisms implicated in -mediated neurodegeneration in PD, as well as the interplay between VPS35 and other PD-linked gene products. This article is part of a discussion meeting issue 'Understanding the endo-lysosomal network in neurodegeneration'.

摘要

()基因编码了内体分选和跨膜货物再循环所必需的逆转运体复合物的核心组成部分。内体溶酶体途径缺陷被认为在神经退行性疾病(包括帕金森病(PD))的发病机制中发挥作用。()中的突变导致迟发性、常染色体显性形式的 PD,单个错义突变(D620N)在 PD 家族中与疾病分离。了解 PD 相关的 D620N 突变如何导致逆转运体功能障碍将为 PD 的病理生理学提供有价值的见解,并可能推进治疗剂的鉴定。D620N VPS35 可以诱导 LRRK2 过度激活并损害 WASH 复合物的内体募集,但也与线粒体和自噬溶酶体途径功能障碍以及神经递质受体运输改变有关。与 D620N 相关的 PD 与散发性 PD 之间的临床相似性表明,在携带突变的细胞和动物模型中观察到的缺陷可能为散发性疾病提供有价值的见解。在这篇综述中,我们强调了围绕 VPS35 及其在 PD 中逆转运体功能障碍中的作用的现有知识。我们对 PD 中与 VPS35 介导的神经退行性变相关的机制以及 VPS35 与其他 PD 相关基因产物之间的相互作用进行了批判性讨论。本文是关于“理解神经退行性疾病中的内体-溶酶体网络”的讨论会议的一部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7037/10874700/5e356401a3eb/rstb20220384f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7037/10874700/5e356401a3eb/rstb20220384f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7037/10874700/5e356401a3eb/rstb20220384f01.jpg

相似文献

1
VPS35 and retromer dysfunction in Parkinson's disease.VPS35 和 retromer 功能障碍与帕金森病。
Philos Trans R Soc Lond B Biol Sci. 2024 Apr 8;379(1899):20220384. doi: 10.1098/rstb.2022.0384. Epub 2024 Feb 19.
2
VPS35, the Retromer Complex and Parkinson's Disease.VPS35、逆转录酶复合物与帕金森病
J Parkinsons Dis. 2017;7(2):219-233. doi: 10.3233/JPD-161020.
3
Mechanisms of -Mediated Neurodegeneration in Parkinson's Disease.帕金森病中α-突触核蛋白介导神经退行性变的机制
Int Rev Mov Disord. 2021;2:221-244. doi: 10.1016/bs.irmvd.2021.08.005. Epub 2021 Sep 30.
4
Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.理解 VPS35 和逆行转运体在神经退行性疾病中的作用。
Neurobiol Dis. 2022 Aug;170:105768. doi: 10.1016/j.nbd.2022.105768. Epub 2022 May 16.
5
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease.VPS35 和 α-突触核蛋白未能相互作用以调节帕金森病啮齿动物模型中的神经退行性变。
Mol Neurodegener. 2023 Aug 4;18(1):51. doi: 10.1186/s13024-023-00641-4.
6
Formation of retromer transport carriers is disrupted by the Parkinson disease-linked Vps35 D620N variant.帕金森病相关 Vps35 D620N 变异破坏了 retromer 转运载体的形成。
Traffic. 2021 Apr;22(4):123-136. doi: 10.1111/tra.12779. Epub 2021 Jan 22.
7
The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer.与帕金森病相关的 Vps35 D620N 突变破坏了 retromer 的货物分拣功能。
Traffic. 2014 Feb;15(2):230-44. doi: 10.1111/tra.12136. Epub 2013 Nov 14.
8
Parkinson's disease-linked knockin mice manifest tau neuropathology and dopaminergic neurodegeneration.帕金森病相关基因敲入小鼠表现出 tau 神经病理学和多巴胺能神经退行性变。
Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5765-5774. doi: 10.1073/pnas.1814909116. Epub 2019 Mar 6.
9
The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.帕金森病 VPS35[D620N]突变增强了小鼠和人类中 LRRK2 介导的 Rab 蛋白磷酸化。
Biochem J. 2018 Jun 6;475(11):1861-1883. doi: 10.1042/BCJ20180248.
10
An update on cellular and molecular determinants of Parkinson's disease with emphasis on the role of the retromer complex.帕金森病的细胞和分子决定因素的最新研究进展,重点介绍了逆向转运复合体的作用。
J Neurosci Res. 2021 Jan;99(1):163-179. doi: 10.1002/jnr.24675. Epub 2020 Jul 7.

引用本文的文献

1
HucMSCs-Derived Extracellular Vesicles Deliver RPS27A Protein to Manipulate the MDM2-P53 Axis and Ameliorate Neurological Dysfunction in Parkinson's Disease.人脐带间充质干细胞衍生的细胞外囊泡递送RPS27A蛋白以调控MDM2-P53轴并改善帕金森病的神经功能障碍
J Neuroimmune Pharmacol. 2025 May 8;20(1):52. doi: 10.1007/s11481-025-10209-2.
2
Microglia: roles and genetic risk in Parkinson's disease.小胶质细胞:在帕金森病中的作用及遗传风险
Front Neurosci. 2024 Nov 1;18:1506358. doi: 10.3389/fnins.2024.1506358. eCollection 2024.
3
Is There a Place for Lewy Bodies before and beyond Alpha-Synuclein Accumulation? Provocative Issues in Need of Solid Explanations.

本文引用的文献

1
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease.VPS35 和 α-突触核蛋白未能相互作用以调节帕金森病啮齿动物模型中的神经退行性变。
Mol Neurodegener. 2023 Aug 4;18(1):51. doi: 10.1186/s13024-023-00641-4.
2
Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.理解 VPS35 和逆行转运体在神经退行性疾病中的作用。
Neurobiol Dis. 2022 Aug;170:105768. doi: 10.1016/j.nbd.2022.105768. Epub 2022 May 16.
3
Mechanisms of -Mediated Neurodegeneration in Parkinson's Disease.
路易体在α-突触核蛋白聚集之前和之后是否有存在的空间?需要确凿解释的有争议问题。
Int J Mol Sci. 2024 Apr 1;25(7):3929. doi: 10.3390/ijms25073929.
帕金森病中α-突触核蛋白介导神经退行性变的机制
Int Rev Mov Disord. 2021;2:221-244. doi: 10.1016/bs.irmvd.2021.08.005. Epub 2021 Sep 30.
4
Autophagy in healthy aging and disease.自噬在健康衰老和疾病中的作用。
Nat Aging. 2021 Aug;1(8):634-650. doi: 10.1038/s43587-021-00098-4. Epub 2021 Aug 12.
5
Neuronal deletion induces spinal cord motor neuron degeneration and early post-natal lethality.神经元缺失会导致脊髓运动神经元变性和出生后早期死亡。
Brain Commun. 2021 Sep 10;3(3):fcab208. doi: 10.1093/braincomms/fcab208. eCollection 2021.
6
Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition.内体运输和谷氨酸突触活性在 VPS35 D620N 突变敲入小鼠神经元中增加,并能抵抗 LRRK2 激酶抑制。
Mol Brain. 2021 Sep 16;14(1):143. doi: 10.1186/s13041-021-00848-w.
7
Parkinson disease-associated cognitive impairment.帕金森病相关认知障碍。
Nat Rev Dis Primers. 2021 Jul 1;7(1):47. doi: 10.1038/s41572-021-00280-3.
8
Modelling Parkinson's Disease: iPSCs towards Better Understanding of Human Pathology.帕金森病建模:诱导多能干细胞助力深入了解人类病理学
Brain Sci. 2021 Mar 14;11(3):373. doi: 10.3390/brainsci11030373.
9
Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies.帕金森病:铁和氧化还原生物学的改变作为解锁治疗策略的关键。
Redox Biol. 2021 May;41:101896. doi: 10.1016/j.redox.2021.101896. Epub 2021 Feb 14.
10
Cellular and molecular pathophysiology in the progression of Parkinson's disease.帕金森病进展中的细胞和分子病理生理学。
Metab Brain Dis. 2021 Jun;36(5):815-827. doi: 10.1007/s11011-021-00689-5. Epub 2021 Feb 18.